Debunking myths in headache diagnosis for the pain practitioner.

Autor:	Yuan H; Jefferson Headache Center, Department of Neurology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Strutner S; School of Medicine, University of California, Irvine, Irvine, California, USA., Yuh C; Department of Physical Medicine & Rehabilitation, University of California, Irvine, Irvine, California, USA., Anand S; Department of Anesthesiology, University of Mississippi University Hospital, Jackson, Mississippi, USA., Chauhan G; Department of Anesthesiology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Prem A; Department of Anesthesiology, University of Mississippi University Hospital, Jackson, Mississippi, USA., Shah S; Department of Anesthesiology & Perioperative Care, University of California, Irvine, Orange, California, USA., Schuster NM; Headache and Pain Neurologist, Center for Pain Medicine, Department of Anesthesiology, University of California, San Diego, La Jolla, California, USA nmschuster@health.ucsd.edu.
Jazyk:	angličtina
Zdroj:	Regional anesthesia and pain medicine [Reg Anesth Pain Med] 2024 Aug 05; Vol. 49 (8), pp. 545-549. Date of Electronic Publication: 2024 Aug 05.
DOI:	10.1136/rapm-2023-104803
Abstrakt:	With headache being one of the most common chief complaints, it is essential for pain practitioners to interpret and differentiate a variety of headache characteristics to accurately diagnose and treat specific headache disorders. Certain misconceptions often lead to misdiagnosis. This article presents and discusses six myths about several common headache disorders (migraine, tension-type headache, cluster headache, cervicogenic headache, sinus headache, and occipital neuralgia) often encountered in clinical practice. The discussion is based primarily on the International Classification of Headache Disorders, 3rd edition and the latest studies. Recognizing and understanding the intricacies behind key headache diagnoses will help providers devise appropriate plans to better care for their patients. Competing Interests: Competing interests: Within the past 24 months, HY has received funding from NIH (R44NS115460); institutional support for serving as an investigator from Teva, Abbvie, Trillen, Thermaquil; consultant fees from Salvia, Pfizer, Cerenovus; and royalties from Cambridge University Press and MedLink. NS has received compensation from Eli Lilly & Co., Averitas, ShiraTronics, Syneos, Schedule 1 Therapeutics, and Vectura Fertin and research funding from Migraine Research Foundation, Novaremed, UCSD Academic Senate, UCSD Department of Anesthesiology RAG, and NIH CTSA Grant UL1TR000100. SS received consulting honorarium from Allergan. (© American Society of Regional Anesthesia & Pain Medicine 2024. No commercial re-use. See rights and permissions. Published by BMJ.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu